Analysts Set American Healthcare REIT, Inc. (NYSE:AHR) PT at $26.00

American Healthcare REIT, Inc. (NYSE:AHRGet Free Report) has earned a consensus rating of “Moderate Buy” from the eight ratings firms that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12 month price target among brokers that have covered the stock in the last year is $26.00.

AHR has been the subject of several research analyst reports. Royal Bank of Canada boosted their price objective on American Healthcare REIT from $28.00 to $30.00 and gave the company an “outperform” rating in a report on Monday, November 18th. Morgan Stanley upped their price target on American Healthcare REIT from $27.00 to $29.00 and gave the company an “overweight” rating in a research report on Monday, December 30th. Finally, Truist Financial raised their price objective on American Healthcare REIT from $27.00 to $29.00 and gave the stock a “buy” rating in a research note on Friday, November 15th.

Read Our Latest Stock Analysis on AHR

American Healthcare REIT Price Performance

AHR opened at $27.64 on Monday. The company has a market capitalization of $4.23 billion and a P/E ratio of -57.59. The company has a 50-day moving average of $28.25 and a 200-day moving average of $25.74. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.37 and a current ratio of 0.37. American Healthcare REIT has a 1-year low of $12.81 and a 1-year high of $29.99.

American Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 17th. Investors of record on Tuesday, December 31st were given a dividend of $0.25 per share. The ex-dividend date of this dividend was Tuesday, December 31st. This represents a $1.00 dividend on an annualized basis and a yield of 3.62%. American Healthcare REIT’s dividend payout ratio is currently -208.33%.

Institutional Investors Weigh In On American Healthcare REIT

Several large investors have recently added to or reduced their stakes in AHR. GF Fund Management CO. LTD. bought a new position in shares of American Healthcare REIT during the fourth quarter worth about $78,000. WCG Wealth Advisors LLC acquired a new position in American Healthcare REIT during the 4th quarter valued at about $460,000. Public Employees Retirement System of Ohio boosted its stake in American Healthcare REIT by 1.9% during the 4th quarter. Public Employees Retirement System of Ohio now owns 216,698 shares of the company’s stock valued at $6,159,000 after purchasing an additional 3,980 shares during the period. Investmark Advisory Group LLC grew its position in American Healthcare REIT by 16.7% in the 4th quarter. Investmark Advisory Group LLC now owns 12,331 shares of the company’s stock worth $350,000 after purchasing an additional 1,768 shares during the last quarter. Finally, First Heartland Consultants Inc. increased its stake in shares of American Healthcare REIT by 11.7% in the fourth quarter. First Heartland Consultants Inc. now owns 11,799 shares of the company’s stock valued at $335,000 after purchasing an additional 1,239 shares during the period. 16.68% of the stock is owned by institutional investors and hedge funds.

American Healthcare REIT Company Profile

(Get Free Report

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

Further Reading

Analyst Recommendations for American Healthcare REIT (NYSE:AHR)

Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.